Literature DB >> 22969866

Antitumor effect of microbubbles enhanced by low frequency ultrasound cavitation on prostate carcinoma xenografts in nude mice.

Yu Wang1, Bing Hu, Xuehong Diao, Jizhen Zhang.   

Abstract

The aim of this study was to investigate the antitumor effect induced by low frequency (20 kHz) ultrasound (US) radiation combined with intravenous injection of microbubbles (Mbs) on prostate carcinoma Du145 xenografts in nude mice. Du145 prostate tumors were percutaneously implanted in 40 nude mice, which were randomly divided into 4 groups (n=10 each): US+Mbs, US, Mbs and control groups. The mice in the US+Mbs group were treated with 20 kHz, 200 mW/cm(2) US radiation and with 0.2 ml Mbs injected intravenously. Mice in the US and Mbs groups were only treated with US radiation and injection of Mbs, respectively. Tumors were measured with sonography, and the ratio of antitumor growth was calculated. The mice were sacrificed 14 days after treatment. Specimens of the tumor tissues were observed pathologically using light microscopy and transmission electron microscopy. Microvessel density and the average optical density of vascular endothelial growth factor were compared among groups by immunohistochemistry. The average gross tumor volume of the US+Mbs group was significantly reduced compared with the other groups following treatment (P<0.05). The ratio of the antitumor growth in the US+Mbs group was significantly greater than that of the US and Mbs group (P<0.05). Histological examination showed signs of tumor cell injury in the US+Mbs group. Examination by electron microscopy revealed vessel injury in the endothelium in the tumors treated with US+Mbs. Microvessel density and the average optical density of vascular endothelial growth factor in the US+Mbs group were significantly less than that of other groups (P<0.05). In conclusion, low frequency US of 20 kHz radiation combined with Mbs may be used to inhibit the growth of human prostate carcinoma xenografts in nude mice, and the effect is likely realized through microvessel destruction caused by cavitation.

Entities:  

Year:  2011        PMID: 22969866      PMCID: PMC3438844          DOI: 10.3892/etm.2011.377

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  26 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Tumour vascularity and proliferation: clear evidence of a close relationship.

Authors:  N Weidner
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

Review 3.  Local drug and gene delivery through microbubbles.

Authors:  E C Unger; E Hersh; M Vannan; T O Matsunaga; T McCreery
Journal:  Prog Cardiovasc Dis       Date:  2001 Jul-Aug       Impact factor: 8.194

Review 4.  The use of ultrasound for drug delivery.

Authors:  K Tachibana; S Tachibana
Journal:  Echocardiography       Date:  2001-05       Impact factor: 1.724

Review 5.  Delivery of drugs with ultrasound.

Authors:  J R Lindner; S Kaul
Journal:  Echocardiography       Date:  2001-05       Impact factor: 1.724

Review 6.  Therapeutic applications of microbubbles.

Authors:  Evan C Unger; Terry Onichi Matsunaga; Thomas McCreery; Patricia Schumann; Robert Sweitzer; Rachel Quigley
Journal:  Eur J Radiol       Date:  2002-05       Impact factor: 3.528

7.  Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery.

Authors:  Kullervo Hynynen; Nathan McDannold; Natalia Vykhodtseva; Scott Raymond; Ralph Weissleder; Ferenc A Jolesz; Nickolai Sheikov
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

8.  Refining histotripsy: defining the parameter space for the creation of nonthermal lesions with high intensity, pulsed focused ultrasound of the in vitro kidney.

Authors:  Kathleen Kieran; Timothy L Hall; Jessica E Parsons; J Stuart Wolf; J Brian Fowlkes; Charles A Cain; William W Roberts
Journal:  J Urol       Date:  2007-06-15       Impact factor: 7.450

Review 9.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Authors:  Daniel J Hicklin; Lee M Ellis
Journal:  J Clin Oncol       Date:  2004-12-07       Impact factor: 44.544

10.  A NEW METHOD FOR THE GENERATION AND USE OF FOCUSED ULTRASOUND IN EXPERIMENTAL BIOLOGY.

Authors:  J G Lynn; R L Zwemer; A J Chick; A E Miller
Journal:  J Gen Physiol       Date:  1942-11-20       Impact factor: 4.086

View more
  5 in total

1.  Optimization of low-frequency low-intensity ultrasound-mediated microvessel disruption on prostate cancer xenografts in nude mice using an orthogonal experimental design.

Authors:  Y U Yang; Wenkun Bai; Yini Chen; Yanduan Lin; Bing Hu
Journal:  Oncol Lett       Date:  2015-09-17       Impact factor: 2.967

2.  Low-frequency ultrasound-mediated microvessel disruption combined with docetaxel to treat prostate carcinoma xenografts in nude mice: A novel type of chemoembolization.

Authors:  Yu Yang; Wenkun Bai; Yini Chen; Shuliang Nan; Yanduan Lin; Tao Ying; Bing Hu
Journal:  Oncol Lett       Date:  2016-06-13       Impact factor: 2.967

3.  Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer.

Authors:  Pintong Huang; Ying Zhang; Jian Chen; Weihui Shentu; Yu Sun; Zhijian Yang; Tingbo Liang; Shuyuan Chen; Zhaoxia Pu
Journal:  Oncotarget       Date:  2015-08-21

4.  Ultrasonic Cavitation Ameliorates Antitumor Efficacy of Residual Cancer After Incomplete Radiofrequency Ablation in Rabbit VX2 Liver Tumor Model.

Authors:  Shi-Yan Li; Pin-Tong Huang; Yong Fang; Yao Wu; Ling Zhou; Jie-Li Luo; Xian-Chen Wang; Yun-Chong Chen
Journal:  Transl Oncol       Date:  2019-06-05       Impact factor: 4.243

5.  Low‑frequency ultrasound and microbubbles combined with simvastatin promote the apoptosis of MCF‑7 cells by affecting the LATS1/YAP/RHAMM pathway.

Authors:  Haige Li; Chen Chen; Dehang Wang
Journal:  Mol Med Rep       Date:  2018-07-12       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.